Cybin is assessing CYB004 inside a phase 2 scientific trial concentrating on generalized anxiety disorder. The drugmaker expects to report topline outcomes from this study in the initial fifty percent of 2025.Gummies aren’t the one psilocybin-infused edibles that are showing on the market. Dozens of other special and impressive products supply th